Background High frequency chest wall oscillation (HFCWO) is standard treatment for airway clearance in the USA ... the short-term effects of HFCWO with usual ACTs in patients with cystic fibrosis ...

This technique is widely recommended by physiotherapy consensus for CF, and its use encourages patient independence, aiming for its incorporation into the daily treatment routine ... function in ...

Cystic fibrosis (CF) is a multi-organ genetic disease estimated ... Until the 2010s, care for pwCF focused on slowing lung disease progression with antibiotics, using physiotherapy and/or inhaled ...

for the treatment of people with cystic fibrosis (CF) ages 6 years and older who have at least one non-class I mutation in the cystic fibrosis transmembrane conductance regulator (CFTR ...

Anyone, of any ethnicity, can get cystic fibrosis. But for decades it has ... For those carrying certain mutations, the treatment is so effective that it is essentially a cure.

"The fibrosis regression in our trial marks a breakthrough in the treatment of CHB fibrosis," said Prof. Lungen Lu, M.D., Dean of the Department of Gastroenterology at Shanghai General Hospital, ...

The successful use of inhaled morphine to relieve dyspnea in a patient with end-stage cystic fibrosis (CF ... decline in pulmonary function. The only treatment for end-stage CF lung disease ...

NHS England has signed an agreement with US pharma Vertex covering all the company’s licensed cystic fibrosis medicines, and any future uses for them. The deal follows a three-year stand off ...

Vertex was the first company to produce a medicine tackling the root cause of cystic fibrosis (CF) – mutations in a gene that codes for ion channels in cells that produce mucus, sweat ...